Even though chemotherapy stands as a standard option in the therapy of TNBC, problems
associated with it such as anemia, bone marrow suppression, immune suppression, toxic …

Triple-negative breast cancer (TNBC), a subtype of breast cancer that lacks expression of
oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …

Breast cancer is the most diagnosed cancer among women. Approximately 15–20% of all
breast cancers are highly invasive triple-negative breast cancer (TNBC) and lack estrogen …

Although photodynamic therapy (PDT) has attracted great interest, the photosensitizers in
clinical had weak inhibition on metastasis and invasion of cancers. Additionally the immune …

Background Triple negative breast cancer (TNBC) represents a significant clinical
challenge. Chemotherapy remains the mainstay for a large part of TNBC patients, whereas …

In triple-negative breast cancer (TNBC), the pleiotropic NDRG1 (N-Myc downstream
regulated gene 1) promotes progression and worse survival, yet contradictory results were …

Triple negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis
and still lacks a targeted therapy. In this study, we found increased ERK phosphorylation in …

Objective To explore the role of p300 in the context of paclitaxel (PTX) resistance in triple-
negative breast cancer (TNBC) cells, focusing on its interaction with the …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer,
having a poor prognosis and rapid metastases. TNBC is characterized by the absence of …

Cancer is a group of diseases characterized by uncontrolled cellular growth, abnormal
morphology, and altered proliferation. Cancerous cells lose their ability to act as anchors …